retatrutide clinical trial duration Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide UK: 2026 Clinical Trial

GLP-1 medications have generally been well-tolerated for long-term use, though they may have mild to moderate side effects such as nausea, vomiting, diarrhea, abdominal discomfort, or occasional constipation

But this can be difficult to achieve due to reduced appetite or taste aversions

Ozempic can cause sickness, vomiting, constipation, and tiredness, among other side effects

The root cause of obesity lies in hormonal imbalances and metabolic dysfunction

While many insurance plans cover GLP-1 drugs for type 2 diabetes, coverage for obesity treatment varies significantly

MEDICATIONS FOR ALL MEDICATIONS, PRESCRIPTION OR OVER-THE-COUNTER, ALWAYS SPEAK WITH YOUR DOCTOR FIRST